Seizing Opportunities in Japan, the Second Largest Innovation-Driven Pharmaceutical Market

Oct 23, 2018
By IQVIA

Register free: http://www.pharmexec.com/pe/biopharma/market

Japan is—and will remain—the second largest market for branded pharmaceuticals and innovation. Continued investment in development and commercialization of pharmaceuticals in Japan is creating many opportunities and growing the potential for multinational biopharma companies. This is driven in part by ongoing regulatory and government initiatives that reward innovation, shifts in population demographics, and increased disease awareness and identifiable patient populations, amongst other factors. Join IQVIA Japan as we discuss how to seize these opportunities and the strong potential outlook for the market in the coming year.

Key Learning Objectives:

  • To obtain the information about the market in Japan
  • How to seize the opportunity in this strong potential market
  • The potential of the market in Japan in coming year

Speaker: Alan Thomas, Director, Thought Leadership, IQVIA Solutions Japan K.K

Date and Time: Tuesday, Oct. 23, 2018 at 6pm EDT
After the final airing of the webcast Tuesday, Oct. 23, 2018 it will be available on demand until Oct. 23, 2019.

Sponsor: IQVIA Solutions

Register free: http://www.pharmexec.com/pe/biopharma/market

native1_300x100
lorem ipsum